Monoclonal antibodies against BSG have also shown efficacy in treatment of hepatocellular carcinoma and hypervascular pancreatic tumours when administered alone or in combination with chemotherapy [170]. The gene discussed is BSG; the disease is hepatocellular carcinoma.